Description
Stanozolol tablets at 2 mg per tablet, bottles of 100, 200 mg in total. The United States oral human product was withdrawn around 2003 and the veterinary injectable approval has lapsed, so no approved stanozolol product remains in either category. Schedule III as an anabolic steroid. Research use only, not for human consumption, adults 21 and over, with purchase restrictions by state.
Container and content
| Compound | Stanozolol |
|---|---|
| Content per unit | 2 mg |
| Units per container | 100 tablets |
| Total content | 200 mg |
| Molecular mass | 328.5 approximately |
| Human US product | Withdrawn around 2003 |
| Veterinary approval | Lapsed |
| Controlled substance status | Schedule III |
| Sold as | Stanozolol tablets, research use only |
Two milligrams per unit is the lowest content in the oral category here, which makes the total small and the price per milligram high. Both follow from the dosage form rather than from stanozolol tablets itself.
We shelve stanozolol tablets with the other the oral dosage forms, under anabolic reference materials.
Stanozolol tablets: the pyrazole ring
A pyrazole fused across the A ring in place of the 3-keto group, a 17-alpha-methyl substituent, and a molecular mass near 328.5. The two ring nitrogens change the acid and base behaviour of the molecule as well as its spectroscopy, and they are the reason this compound is so distinctive on a chromatogram.
Weak ultraviolet absorbance is the practical consequence. A certificate for stanozolol tablets that reports purity without naming the detection method is leaving out the part that determines whether the figure means anything.
Two hundred milligrams per bottle
100 tablets at 2 mg is 200 mg. At $150 that is $0.75 per milligram, one of the higher figures on the oral shelf. The 10 mg laboratory presentation holds five times the total for less than half the price and divides to $0.069.
That is an order-of-magnitude difference between two listings of the same compound on the same site, and we print both. Price per milligram beats the price on the bottle explains why.
No approved product in either category
This one is unusual in having lost approvals on both the human and the veterinary side. The oral human product was withdrawn around 2003 and the veterinary injectable approval has lapsed, so nothing containing stanozolol tablets is approved in the United States today. It remains Schedule III. The DEA’s scheduling pages and the FDA’s approval databases are the sources.
The assay, and the lots that fail it
Every lot of stanozolol tablets is assayed before it is listed. HPLC returns purity as a percentage of total peak area, mass spectrometry confirms identity against the expected mass, and residual solvents are reported in parts per million. A lot assaying below its stated milligram content is withdrawn from sale, and its certificate stays on the results page with the rest of them, because a results page carrying nothing but passes tells you nothing about the ones that did not pass. The figure published is the figure the assay returned, not a rounded version of it.
Why we publish the batch that failed is the longer version of that argument, and our certificate guide covers the fields.
Container, label and lot
The label on stanozolol tablets carries the compound name, the content per unit, the container count or fill volume, the lot number and the date the lot was assayed. Those five things are what make a reference material traceable, and a container missing any of them is a container of unknown provenance whatever is written on the invoice. Storage conditions for this item are printed on the listing. Sealed containers are shipped sealed, and we do not repackage into unlabelled vials or bottles on request.
Declined on request
No quantities, no protocols, no sequencing, no potency rankings, no physiological description of this compound. If you ask us by email, the answer is the same as the answer on the page, which is that we do not supply it.
Keeping this listing to specifications is what makes the specifications worth anything. Research use only is not a legal strategy, and the FDA has said so in writing explains how the agency reads pages that go further, and the FDA’s drug information section holds the source documents.
Research use only. Not for human consumption. Adults 21 and over, purchase restrictions by state, both stated on the listing for this item and enforced at checkout. Not a drug, not a dietary supplement, not a food. The lot certificate for this item and the full archive, failures included, are published on the lab results page.
US regulatory status. No stanozolol product is currently approved or marketed for human use in the United States.
Reviews
There are no reviews yet.